334 results
S-3/A
ACGN
Aceragen Inc
17 Jul 97
Shelf registration (amended)
12:00am
completed human clinical trials of a product based on antisense
technology, and there can be no assurance that any of the Company's products … on the genetic material chosen
as the site of action of the oligonucleotide. There can be no assurance that the
Company's choice will be appropriate
8-K
EX-99.1
ACGN
Aceragen Inc
23 Jan 98
Current Report
12:00am
% Notes
to exchange such 9% Notes for preferred stock and warrants of the Company (the
"Exchange Offer"). There can be no assurance … the
expectations, beliefs, intentions or strategies regarding the future. There can
be no assurance (i) as to the amount of proceeds which may be received from
8-K
EX-99.1
ACGN
Aceragen Inc
19 Nov 97
Hybridon, Inc.
12:00am
. There can be no assurance that the Company will
receive gross proceeds from the Private Offering of at least $12.5 million or
as to when or if the Company … will ever consummate the Private Offering. There
can also be no assurance that the terms of the Private Offering will not
change from those described
8-K
EX-99.1
2c721a87omcon207jacv
25 Jul 97
Other events
12:00am
S-1
qdgakha ey
23 Dec 98
IPO registration
12:00am
8-K
EX-99.1
o07lnwddbq4 jc58tobs
10 Dec 97
Hybridon, Inc.
12:00am